Kesler Norman & Wride’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.01M Sell
2,592
-172
-6% -$72.7K 0.16% 143
2026
Q1
$1.31M Buy
2,764
+17
+0.6% +$8.56K 0.23% 102
2025
Q4
$1.28M Buy
2,747
+904
+49% +$420K 0.22% 104
2025
Q3
$553K Sell
1,843
-766
-29% -$297K 0.11% 170
2025
Q2
$1M Sell
2,609
-57
-2% -$20.5K 0.18% 121
2025
Q1
$921K Buy
2,666
+823
+45% +$265K 0.18% 115
2024
Q4
$553K Buy
+1,843
New +$644K 0.12% 165

Other funds holding HCA

Kesler Norman & Wride's HCA Position: Q2 2026 in Review

Kesler Norman & Wride reduced its HCA Healthcare (HCA) stake by 6.2% in Q2 2026, selling an estimated $72.7K and leaving 2,592 shares worth $1.01M. The position accounts for 0.16% of the portfolio, ranked #143.

Kesler Norman & Wride first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.31M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Kesler Norman & Wride held 2,592 shares of HCA Healthcare worth $1.01M as of Q2 2026.
  • Kesler Norman & Wride sold 172 HCA Healthcare shares in Q2 2026, an estimated $72.7K.
  • HCA Healthcare made up 0.16% of Kesler Norman & Wride's portfolio in Q2 2026, its #143 holding.
  • Kesler Norman & Wride first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Kesler Norman & Wride's HCA Healthcare position peaked at $1.31M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Kesler Norman & Wride's 13F filing for Q2 2026, filed 23 Jul 2026.